Biochemistry, Genetics and Molecular Biology
Messenger RNA
100%
Programmed Cell Death
100%
Cell Cycle Progression
100%
Cell Proliferation
50%
Flow Cytometry
50%
Anticancer
50%
Mitochondrial Membrane Potential
50%
Western Blot
25%
Cell Cycle
25%
P53
25%
Cytochrome C
25%
Phosphatidylserine
25%
DNA Fragmentation
25%
Bcl-2
25%
Caspase 3
25%
Antineoplastic Activity
25%
P21
25%
S Phase
25%
Chromatin Condensation
25%
Cyclin A
25%
Caspase-9
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Cdc25
25%
Sulforhodamine B
25%
Keyphrases
Induced Apoptosis
100%
Cell Cycle Progression
100%
MCF-7 Cancer Cell Line
100%
Licochalcone B
100%
Protein Level
50%
MCF-7 Cells
41%
MRNA Level
33%
Flow Cytometry
16%
Mitochondrial Membrane Potential
16%
Anticancer Activity
16%
Cyclin A
8%
Western Blot
8%
Quantitative PCR
8%
Apoptosis
8%
Cytochrome c (Cyt c)
8%
Caspase-3
8%
Caspase-9
8%
DNA Fragmentation
8%
Phosphatidylserine Externalization
8%
Cell Cycle Proteins
8%
Chromatin Condensation
8%
Anticancer Effect
8%
Anti-inflammatory Agents
8%
Cyclin-dependent Kinase 2 (CDK2)
8%
Cdc25
8%
B-cell Lymphoma 2 (Bcl-2)
8%
S-phase Arrest
8%
P53 Protein
8%
Sulforhodamine B Assay
8%
Apoptosis-related Proteins
8%
JC-1 Staining
8%
Alternative Compounds
8%
Cell Proliferation Activity
8%
Recent Patents
8%
Human Breast Cancer
8%
Immunology and Microbiology
Programmed Cell Death
100%
Cell Cycle Progression
100%
Mitochondrial Membrane Potential
66%
Caspase
66%
Cell Proliferation
66%
Cytochrome
33%
P53
33%
Western Blot
33%
Bcl-2
33%
Cell Cycle
33%
DNA Fragmentation
33%
Antineoplastic Activity
33%
Chromatin Condensation
33%
Cyclin A
33%
Quantitative Reverse Transcription Polymerase Chain Reaction
33%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Licochalcone B
100%
Messenger RNA
33%
Malignant Neoplasm
16%
Flow Cytometry
16%
Cyclin A
8%
Protein P53
8%
Western Blot
8%
Cytochrome C
8%
Caspase 3
8%
Caspase 9
8%
Phosphatidylserine
8%
Antiinflammatory Agent
8%
Sulforhodamine B
8%